Complement factor B blockade by iptacopan drives antitumor complement-based immunomodulation in pancreatic cancer microenvironment.
- DOI
- 10.1016/j.ajpath.2026.08.005
- Published
- 2026 Sep 21
- Container
- The American journal of pathology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ajpath.2026.08.005,
title = {Complement factor B blockade by iptacopan drives antitumor complement-based immunomodulation in pancreatic cancer microenvironment.},
author = {Zhou D and Takano S and Sogawa K and Moriyasu R and Takayashiki T and Suzuki D and Sakai N and Ohtsuka M},
year = {2026},
journal = {The American journal of pathology},
doi = {10.1016/j.ajpath.2026.08.005},
url = {https://doi.org/10.1016/j.ajpath.2026.08.005}
}RIS
TY - JOUR TI - Complement factor B blockade by iptacopan drives antitumor complement-based immunomodulation in pancreatic cancer microenvironment. AU - Zhou D AU - Takano S AU - Sogawa K AU - Moriyasu R AU - Takayashiki T AU - Suzuki D AU - Sakai N AU - Ohtsuka M PY - 2026 JO - The American journal of pathology DO - 10.1016/j.ajpath.2026.08.005 UR - https://doi.org/10.1016/j.ajpath.2026.08.005 ER -
APA
D, Z., S, T., K, S., R, M., T, T., D, S., N, S., & M, O. (2026). Complement factor B blockade by iptacopan drives antitumor complement-based immunomodulation in pancreatic cancer microenvironment.. The American journal of pathology. https://doi.org/10.1016/j.ajpath.2026.08.005
Source records
- pubmed · retrieved 2026-09-25T01:17:53.609Z